Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Neurol Sci. 2021 Jul;42(7):2615-2618. doi: 10.1007/s10072-021-05253-8. Epub 2021 Apr 15.
Psychological well-being assessment during the COVID-19 pandemic is essential for patients with multiple sclerosis (MS). The goal of this study is to evaluate fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of Iranian patients with MS during the COVID-19 pandemic stage.
One hundred and sixty-five patients were enrolled. We asked all cases to fill valid and reliable Persian version of depression, anxiety, and stress scale (DASS-21), perceived social support, and fear of relapse scale questionnaires.
One hundred and sixty-five patients were enrolled. Female to male ratio was (F/M) = 4.6. Mean age and mean duration of disease were 35.3±8.6 and 7.1±5 years, respectively. Mean scores of social support, DASS, and FoR questionnaires were 63.1±16.8, 16.4±13.4, and 51.4±17.3, respectively. There was a significant negative correlation between social support and FoR scores and also significant positive correlations between components of DASS and FoR. Linear regression analysis by considering FoR as dependent variable and age, sex, marital status, duration of the disease, and EDSS as dependent variables showed that sex was an independent predictor of FoR score.
Psychological well-being as well as fear of relapse should be considered in patients with MS during the COVID-19 pandemic stage.
在 COVID-19 大流行期间,对多发性硬化症 (MS) 患者进行心理健康评估至关重要。本研究旨在评估 COVID-19 大流行期间伊朗 MS 患者的恐惧复发、社会支持和心理健康(抑郁、焦虑和压力水平)。
共纳入 165 名患者。我们要求所有患者填写有效的和可靠的波斯语版抑郁、焦虑和压力量表 (DASS-21)、感知社会支持和恐惧复发量表问卷。
共纳入 165 名患者。男女比例为 (F/M) = 4.6。平均年龄和平均病程分别为 35.3±8.6 岁和 7.1±5 年。社会支持、DASS 和 FoR 问卷的平均得分为 63.1±16.8、16.4±13.4 和 51.4±17.3。社会支持与 FoR 评分呈显著负相关,DASS 各成分与 FoR 评分呈显著正相关。考虑 FoR 为因变量,年龄、性别、婚姻状况、病程和 EDSS 为因变量的线性回归分析表明,性别是 FoR 评分的独立预测因子。
在 COVID-19 大流行期间,应考虑 MS 患者的心理健康和恐惧复发。